News from us and our partners

Tags

Topics

0 results

News
2 July, 2026
Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M)
News
1 July, 2026
Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares
News
30 June, 2026
Biotalys Announces Retirement of Board Member Patrick Van Beneden
News
30 June, 2026
DNA Script expands access to on-demand DNA synthesis in India through distributor agreement with Imperial Life Sciences.
News
30 June, 2026
Muna Therapeutics Announces CEO Transition as Clinical Pipeline Advances
News
30 June, 2026
Partnership with French cancer research network FFCD expands Bioptimus’s STELA programme
News
30 June, 2026
Moon Surgical and Uncovr Announce First 20 Clinical Cases of Automated Operative Reporting on Maestro®
News
29 June, 2026
Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance Safety Database
News
29 June, 2026
“Health is Wealth”: Why Europe must act now to strengthen its Life Sciences industry
News
25 June, 2026
ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform
News
24 June, 2026
TISSIUM secures €60 million to support commercial and clinical activities and platform expansion
News
24 June, 2026
BrightHeart Announces CE Mark and European Launch of its AI Platform for Prenatal Ultrasound
News
23 June, 2026
Latent Labs to launch Latent-Y Research Tier with a Live Event in London
News
23 June, 2026
Mediar Therapeutics Announces First Cohorts Dosed in Phase 1 Clinical Trial of MTX-439 for Fibrosis Associated with Chronic Kidney Disease (CKD) and Additions to Clinical Advisory Board
News
23 June, 2026
Micropep Files First Regulatory Submissions for Promisin™, a Novel Peptide Biofungicide with a New Mode of Action
News
23 June, 2026
How a Sofinnova Partner's thesis became a $165M biotech

Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M)

Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares

Biotalys Announces Retirement of Board Member Patrick Van Beneden

DNA Script expands access to on-demand DNA synthesis in India through distributor agreement with Imperial Life Sciences.

Muna Therapeutics Announces CEO Transition as Clinical Pipeline Advances

Partnership with French cancer research network FFCD expands Bioptimus’s STELA programme

Moon Surgical and Uncovr Announce First 20 Clinical Cases of Automated Operative Reporting on Maestro®

Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance Safety Database

“Health is Wealth”: Why Europe must act now to strengthen its Life Sciences industry

ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform

TISSIUM secures €60 million to support commercial and clinical activities and platform expansion

BrightHeart Announces CE Mark and European Launch of its AI Platform for Prenatal Ultrasound

Latent Labs to launch Latent-Y Research Tier with a Live Event in London

Mediar Therapeutics Announces First Cohorts Dosed in Phase 1 Clinical Trial of MTX-439 for Fibrosis Associated with Chronic Kidney Disease (CKD) and Additions to Clinical Advisory Board

Micropep Files First Regulatory Submissions for Promisin™, a Novel Peptide Biofungicide with a New Mode of Action

How a Sofinnova Partner's thesis became a $165M biotech